Deleterious effects of adrenocorticotrophic hormone administration during late pregnancy upon offspring somatic, neurological, and sexual development in mice.
The influence of administration of adrenocorticotrophic hormone (ACTH) during days 12-17 of pregnancy upon somatic, neurological, and neuromuscular development of offspring in mice was studied. The effects upon the onset of puberty in female offspring was also examined. Litters from mice given the higher of two doses of ACTH (1 IU/day or 8 IU/day) showed lower body weights at birth and weaning than controls. This treatment also increased pre- and postnatal mortality rates, although not significantly. Litters from mice treated with either dose of ACTH showed retarded development of the forelimb and hindlimb grasp reflexes, the body righting reflex, the auditory startle response, and eye opening. Although ear opening was delayed in litters from ACTH-treated mice, results did not achieve statistical significance. Study of female offspring housed in small groups revealed that one indicator of puberty, vaginal opening, was delayed in female offspring of ACTH-treated mice. Experiments were conducted to identify factors mediating this syndrome: ACTH did not depress maternal food intake or alter the length of pregnancy, therefore fetal undernutrition or premature birth can be excluded as mediating factors. All litters were fostered to untreated mice to control for postnatal factors influencing development. As ACTH cannot cross the placenta, the syndrome is likely to result from in utero exposure to abnormally high concentrations of glucocorticosteroids of maternal origin. It is concluded that such alterations to the fetal environment can exert a deleterious influence upon somatic, neurological, and sexual development, and that hormones of the maternal pituitary-adrenocortical axis may naturally act to regulate general development of the fetus.
D000324:Adrenocorticotropic Hormone / Q000633:toxicity*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D004431:Ear, External / Q000254:growth & development; D004435:Eating / Q000187:drug effects; D005260:Female; D005313:Fetal Death / Q000139:chemically induced; D005865:Gestational Age; D008098:Litter Size / Q000187:drug effects; D008431:Maternal-Fetal Exchange; D051379:Mice; D009132:Muscles / Q000196:embryology / Q000294:innervation; D009420:Nervous System / Q000196:embryology; D010913:Pituitary-Adrenal System / Q000196:embryology*; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects*; D012018:Reflex; D012741:Sexual Maturation / Q000187:drug effects; D013723:Teratogens
D013723:Teratogens; D000324:Adrenocorticotropic Hormone